Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa L. Johnson, Alexander I. Spira, Navid Hafez et al.|Clinical Cancer Research|2021Cited by 61
Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancerAliccia Bollig‐Fischer, Hirva Mamdani|Molecular Biomedicine|2021Cited by 12